Published in Infect Immun on April 01, 2002
Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2007) 1.33
Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis. PLoS Pathog (2010) 1.10
Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2009) 0.98
Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity. Exp Eye Res (2007) 0.98
A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis. Intensive Care Med (2005) 0.96
Disruption of contact lens-associated Pseudomonas aeruginosa biofilms formed in the presence of neutrophils. Invest Ophthalmol Vis Sci (2011) 0.92
In vitro hematological and in vivo vasoactivity assessment of dextran functionalized graphene. Sci Rep (2013) 0.88
Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology (2007) 0.87
Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology. Invest Ophthalmol Vis Sci (2013) 0.87
Inhibition by female sex hormones of collagen degradation by corneal fibroblasts. Mol Vis (2011) 0.82
Protective Role of Surfactant Protein D in Ocular Staphylococcus aureus Infection. PLoS One (2015) 0.79
Corneal stromal cells selectively inhibit production of anti-inflammatory cytokines by activated T cells. Clin Exp Immunol (2004) 0.79
Tripartite Motif 8 (TRIM8) Positively Regulates Pro-inflammatory Responses in Pseudomonas aeruginosa-Induced Keratitis Through Promoting K63-Linked Polyubiquitination of TAK1 Protein. Inflammation (2017) 0.75
Tissue destruction by neutrophils. N Engl J Med (1989) 13.81
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J (1990) 5.16
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol (1997) 4.94
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (1990) 4.46
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood (1994) 3.74
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun (1997) 3.49
Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun (1995) 2.80
Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun (1996) 2.40
Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun (1994) 2.37
Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun (1995) 2.27
Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet (1993) 2.05
Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci (1998) 1.77
Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci (1998) 1.74
Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem (1995) 1.71
Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase. Infect Immun (1986) 1.55
Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J Immunol (2000) 1.55
An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J Immunol (1991) 1.42
Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. Curr Eye Res (1983) 1.29
Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev (1999) 1.28
Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease. Infect Immun (1986) 1.22
Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation (1997) 1.21
Post-transcriptional regulation of gro alpha, beta, gamma, and IL-8 mRNAs by IL-1 beta. Nucleic Acids Res (1991) 1.21
Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler (1995) 1.18
Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci (2000) 1.17
Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice. Infect Immun (1998) 1.14
Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci (1998) 1.14
Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha. Invest Ophthalmol Vis Sci (2000) 1.13
Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett (1989) 1.11
Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect Immun (1997) 1.11
Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci (1991) 1.10
Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res (1998) 1.07
Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol (1997) 1.06
Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res (1996) 1.04
Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect Immun (1979) 1.03
Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab (1994) 1.00
In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci (1995) 1.00
Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci (1995) 0.99
Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. Exp Eye Res (1998) 0.97
Characterization of the inflammatory response induced by corneal infection with Pseudomonas aeruginosa. J Ocul Pharmacol (1994) 0.95
Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa. Infect Immun (1999) 0.91
Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines. Infect Immun (2000) 0.91
Therapy of Pseudomonas aeruginosa eye infections. Antibiot Chemother (1971) (1987) 0.89
An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse model. Exp Eye Res (1998) 0.88
In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice. Curr Eye Res (1997) 0.88
Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci (1995) 0.87
Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation. Invest Ophthalmol Vis Sci (1999) 0.86
[The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa]. Fortschr Ophthalmol (1989) 0.86
IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells. J Immunol (1991) 0.82
A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient. Curr Eye Res (2000) 0.82
The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. J Clin Immunol (1998) 0.82
Differential expression of human corneal and perilimbal ICAM-1 by inflammatory cytokines. Invest Ophthalmol Vis Sci (1992) 0.81
Effect of Pseudomonas aeruginosa exotoxin A on endotoxin-induced tumour necrosis factor production in murine lung. J Med Microbiol (1999) 0.80
CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts. Clin Exp Immunol (1999) 0.80
Chemotactic activity of tears and bacteria isolated during adverse responses. Exp Eye Res (1998) 0.78
The regulation of matrix metalloproteinase production in human colonic fibroblasts. Ann N Y Acad Sci (1998) 0.77
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med (1993) 4.94
Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science (1993) 4.75
Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med (1993) 4.41
The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry (1990) 4.10
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med (1990) 3.42
Contact lenses and other risk factors in microbial keratitis. Lancet (1991) 3.04
Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology (2001) 2.90
Longitudinal study of outcome of chronic fatigue syndrome. BMJ (1994) 2.73
Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med (1994) 2.18
Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust (1990) 2.17
What is myalgic encephalomyelitis? Lancet (1988) 2.17
A controversial consensus--comment on article by Broderick et al. J Intern Med (2011) 2.06
Chemokines: leucocyte recruitment and activation cytokines. Lancet (1997) 2.05
Monoclonal gammopathy: benign or not? Aust N Z J Med (1999) 2.03
Eosinophilia-myalgia syndrome associated with L-tryptophan use. Med J Aust (1990) 2.03
Immunological abnormalities in the chronic fatigue syndrome. Med J Aust (1989) 1.95
Possible environmental sources of Acanthamoeba spp in contact lens wearers. Br J Ophthalmol (1992) 1.91
Transmission of hepatitis C within Australian prisons. Med J Aust (1999) 1.89
Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A (1994) 1.84
Iowa's National Laboratory for the study of Rural Telemedicine: a description of a work in progress. Bull Med Libr Assoc (1995) 1.62
Fatigue in selected primary care settings: sociodemographic and psychiatric correlates. Med J Aust (1996) 1.55
The pathogenesis of pterygia. Curr Opin Ophthalmol (1999) 1.55
Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol (1998) 1.54
Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol (2006) 1.53
What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry (2001) 1.51
In vivo confocal microscopy of the human cornea. Br J Ophthalmol (2003) 1.46
Tracing the fate of limbal epithelial progenitor cells in the murine cornea. Stem Cells (2015) 1.45
Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res (1996) 1.43
Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis. J Appl Microbiol (1998) 1.42
Chronic fatigue syndrome: current perspectives on evaluation and management. Med J Aust (1995) 1.41
Treatment of refractory neurosarcoidosis with TNF-inhibitors: what lies ahead? Intern Med J (2012) 1.40
The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol (1985) 1.39
Red blood cell morphology in chronic fatigue syndrome. Lancet (1989) 1.38
Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology (2008) 1.36
Chemokines in acute anterior uveitis. Curr Eye Res (1997) 1.34
Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. J Immunol (1998) 1.30
Immunological determinants of the outcomes from primary hepatitis C infection. Cell Mol Life Sci (2009) 1.25
Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med (2004) 1.24
In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? J Infect Dis (1998) 1.23
Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J Viral Hepat (2010) 1.23
Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci (2000) 1.21
Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci (2000) 1.17
Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol (2007) 1.15
Phosphorylation and nuclear localization of the varicella-zoster virus gene 63 protein. J Virol (1996) 1.14
Role of lactoferrin in the tear film. Biochimie (2008) 1.14
Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med (1995) 1.13
Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage. Stroke (2001) 1.13
Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens (2010) 1.12
Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol (1987) 1.12
Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest (1998) 1.09
Uveitis: aetiology and disease associations in an Australian population. Aust N Z J Ophthalmol (1986) 1.08
The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials (2004) 1.08
Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Pathol (1996) 1.07
The effect of short term contact lens wear on the tear film and ocular surface characteristics of tolerant and intolerant wearers. Cont Lens Anterior Eye (2006) 1.07
Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res (1998) 1.07
Chemokines and serpentines: the molecular biology of chemokine receptors. J Leukoc Biol (1993) 1.07
Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol (1994) 1.06
Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials (2004) 1.06
Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol (1997) 1.06
Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology (1994) 1.05
Screening for prolonged fatigue syndromes: validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol (2000) 1.04
Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res (1996) 1.04
Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol (1998) 1.02
Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Med J Aust (2001) 1.02
Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s. Med J Aust (2000) 1.02
Immunopathogenesis of hepatitis C virus infection. Immunol Cell Biol (2001) 1.01
Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol (1992) 1.01
Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect Immun (1984) 1.01
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug Alcohol Depend (2010) 1.01
Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene. J Immunol (1994) 1.01
Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol (1998) 1.00
Biofilm-related infections in ophthalmology. Eye (Lond) (1995) 0.99
Role and regulation of CXC-chemokines in acute experimental keratitis. Exp Eye Res (2003) 0.99
Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat. Exp Neurol (2001) 0.98
Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. Br J Psychiatry (1997) 0.98
Expression of TNF-alpha by human plasma cells in chronic inflammation. J Leukoc Biol (1997) 0.98
Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci (2001) 0.98
Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol (1986) 0.97
CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut (2004) 0.96
Lipid, lipase and lipocalin differences between tolerant and intolerant contact lens wearers. Curr Eye Res (2002) 0.95
Spectrum of sarcoidosis involving the eye and brain. Aust N Z J Ophthalmol (1997) 0.95
Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment. Invest Ophthalmol Vis Sci (1999) 0.95
'Sterile' corneal infiltrates in contact lens wearers. Eye (Lond) (1989) 0.95
Susac syndrome: microangiopathy of the retina, cochlea and brain. Clin Experiment Ophthalmol (2000) 0.94
Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. J Biol Chem (1994) 0.94
Antibodies to HIV are produced within the central nervous system of all subjects with all categories of HIV infection. Aust N Z J Med (1988) 0.94
Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sjögren syndrome: comparison with tonsillar lymphoid follicles. Ann Rheum Dis (1997) 0.93
Diagnosing pediatric asthma: validating the Easy Breathing Survey. J Pediatr (2001) 0.93
Immunological features of HLA-B27 anterior uveitis. Aust J Ophthalmol (1983) 0.93
Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J Clin Invest (1994) 0.93
Cyclosporin therapy in Mooren's ulcer. Br J Ophthalmol (1987) 0.93
The relationship between fatigue, psychological and immunological variables in acute infectious illness. Aust N Z J Psychiatry (1998) 0.93